Nedaplatin(GMP) -
Nedaplatin(GMP) For Sale, Most Competitive Price, Fast Delivery, Custom Service, Wholesale Nedaplatin(GMP), Made in China, High Quality Products!, China Nedaplatin, ,95734-82-0 Supplier, Manufacturer.
CAS:
95734-82-0
Introduction:
Nedaplatin is a platinum compound which is used for cancer chemotherapy, It is a derivative of cisplatin, but It produces less nausea, vomiting and nephrotoxicity than cisplatin. Nedaplatin is primarily used in patients with the cancer of head and neck, small cell lung carcinoma, non-small-cell lung carcinoma, esophageal cancer, and other solid tumors.
Simcere's Nedaplatin API:
Simcere抯 JIebaishu is the first marketed injection of Nedaplatin in China.
Simcere抯 API and preparations of Nedaplatin are both successfully passed and received SFDA GMP certification.
Some inspection data
Specification CP
Properties Off white or yellowish crystalline powder
PH 6.6
Loss on drying 0.5% max
Total bacteria 100 cfu/g max
Yeasts and Moulds 10 cfu/g max
Escherichia coli Not detected
Assay 99.6 %
Simcere Pharmaceutical Group
Address: No.699-18, Xuanwu Avenue Nanjing, P. R. China, Nanjing, Jiangsu, China, 210042
Tel: +86 (25) 8556 6666-8851
Founded in 1995 with a vision to establish a company that would in turn help create a healthier China, Simcere Pharmaceutical Group has become a leading manufacturer and supplier of drugs in the rapidly growing China pharmaceutical market, we now have seven certified Good Manufacturing Practices ("GMP") manufacturing facilities and three research and development center and over 4,000 employees. Now Simcere has more than 20 Innovative Pharmaceuticals which are under development, and they all have independent intellectual property rights. In 2010, From them we submited five clinical trial applications to the SFDA.
In 2007 Simcere successfully landed the New York Stock Exchange (ticker symbol SCR) as the first one in mainland China's chemical and biological drugs NYSE-listed company. Simcere is actively increasing our collaborations with international companies (such as Bristol-Myers Squibb Company) to develop new drugs. August 2011, Simcere signed a cooperation framework agreement with Merck to establish a company, provide patients with more high-quality drugs.
Simcere has more than 20 kinds of bulk drug products have passed the GMP certification. Their preparations are saled in China for many years. The raw materials and preparations of Montmorillonite both successfully passed and received EU GMP certification.
Simcere API's advantage comes from good quality. We have a very strict and continuous improvement of the quality management system. This effectively ensures verification from production equipment, raw materials, processing, semi-finished and finished product to ensure stable production process and quality.
Simcere is committed to providing our customers with excellent quality products, simple and efficient service, and Simcere has been concerned with environmental, health and safety issues.
We are looking forward to become a trusty cooperator in the pharmaceutical industry.
